INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
RM
Rodrigues Fernando M.President of BetterHelp
TDOCTeladoc Health, Inc.
Open-market sale · 10b5-1 plan
SELL$17K
2,324 sh
Dec 2, 2025Dec 3, 2025
Page 432 of 481
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
traded Dec 2, 2025
+1d
SEC Form 4

Evidence

23
BC
Banks Matthew C.VP, CAO
ROKUROKU, INC
Open-market sale · 10b5-1 plan
SELL$70K
731 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

23
Sylebra Capital LlcSee Footnote
PIIMPINJ INC
Open-market sale
SELL$7.04M
41.9K sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

23
Sylebra Capital LlcSee Footnote
PIIMPINJ INC
Open-market sale
SELL$5.19M
31.1K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

23
AS
Ahamad SamsheerSee Remarks
SITMSITIME Corp
Open-market sale · 10b5-1 plan
SELL$1.16M
4,000 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

21
SA
Still AshleyDirector
DASHDoorDash, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
62 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

21
GA
Gil Alexis IIChief Accounting Officer
IASINTEGRAL AD SCIENCE HOLDING CORP.
Open-market sale
SELL$29K
2,781 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

21
SP
Sachdeva PrernaChief Accounting Officer
ALKTALKAMI TECHNOLOGY, INC.
Open-market sale
SELL$22K
1,101 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

21
LY
Lim Zi YaoGeneral Counsel
KLICKULICKE & SOFFA INDUSTRIES INC
Open-market sale
SELL$45K
1,000 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

20
KA
Kerdman AlinaSVP, Controller & CAO
CTSHCOGNIZANT TECHNOLOGY SOLUTIONS CORP
Open-market sale · 10b5-1 plan
SELL$12K
151 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

19
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$161K
2,128 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

19
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$67K
904 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

19
FR
Fukushima RyanChief Operating Officer
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$150K
1,968 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

19
SR
Sivaram RohanCHIEF FINANCIAL OFFICER
CFLTConfluent, Inc.
Open-market sale · 10b5-1 plan
SELL$177K
8,000 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

16
HJ
Hennessy Daniel JDirector
INVInnventure, Inc.
Open-market sale · 10b5-1 plan
SELL$421K
82.0K sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

16
SE
Schubach Sarah ElizabethChief Accounting Officer
DBXDROPBOX, INC.
Open-market sale · 10b5-1 plan
SELL$35K
1,168 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

16
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$364K
1,527 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

13
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
250 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

13
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$178K
749 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

13
MS
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS
NTRANatera, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
474 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

10
RM
Roth James MChief Revenue Officer
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$3,472
343 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

10
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$4,194
428 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$18K
92 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
MA
McGrane AshleyGeneral Counsel and Corp Sec
GTMZoomInfo Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$729
72 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$18K
92 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$35K
179 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$6,000
30 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
SN
Sieffert Kristen NPresident
FOAFinance of America Companies Inc.
Open-market sale · 10b5-1 plan
SELL$18K
750 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$4,582
23 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
HJ
Hennessy Daniel JDirector
INVInnventure, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
8,450 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$9,203
47 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

6
KW
Kozarich John WDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$785
4 sh
Dec 1, 2025Dec 3, 2025
traded Dec 1, 2025
+2dSEC Form 4

Evidence

5
SH
Shah HusnalChief Product Officer
FNKOFunko, Inc.
Open-market sale · 10b5-1 plan
SELL$837
263 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

5
KM
Kalesnik Laura MarieSee remarks
VRNOVerano Holdings Corp.
Open-market sale · 10b5-1 plan
SELL$5,558
5,850 sh
Dec 2, 2025Dec 3, 2025
traded Dec 2, 2025
+1dSEC Form 4

Evidence

42
JL
Jackson LawrenceDirector
NOWServiceNow, Inc.
Open-market sale
SELL$215K
265 sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC Form 4

Evidence

41
MP
Manulife (Singapore) Pte. Ltd.10% Owner
NANAJohn Hancock GA Senior Loan Trust
Open-market sale
SELL$50.00M
3.07M sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC Form 4

Evidence

37
PK
Piskel KyleChief Financial Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$3.17M
162.8K sh
Nov 28, 2025Dec 2, 2025
traded Nov 28, 2025
+4dSEC Form 4

Evidence

33
BT
Bar-Zeev TomerDirector
UUnity Software Inc.
Open-market sale · 10b5-1 plan
SELL$2.66M
62.9K sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC Form 4

Evidence

33
BT
Bar-Zeev TomerDirector
UUnity Software Inc.
Open-market sale · 10b5-1 plan
SELL$7.82M
187.1K sh
Dec 1, 2025Dec 2, 2025
traded Dec 1, 2025
+1dSEC Form 4

Evidence

33
UJ
Underwood JeffSVP, GM Contractor Solutions
CSWCSW INDUSTRIALS, INC.
Open-market sale
SELL$103K
370 sh
Dec 2, 2025Dec 2, 2025
traded Dec 2, 2025
+0dSEC Form 4

Evidence

FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K